Europe Latent TB Detection Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)

No. of Pages: 116    |    Report Code: TIPRE00024699    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Latent TB Detection Market

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Latent TB Detection Market – By Test

1.3.2        Europe Latent TB Detection Market – By End User

1.3.3        Europe Latent TB Detection Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Latent TB Detection Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

5.           Europe Latent TB Detection Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Tuberculosis

5.1.2        Rising Government Initiatives to Promote Tuberculosis Detection

5.2         Market Restraints

5.2.1        Existance of Multidrug Resistant Tuberculosis (MDR-TB)

5.3         Market Opportunities

5.3.1        Rise of Market in Emerging Economies

5.4         Future Trends

5.4.1        Surging Advancements in Tuberculosis Diagnosis

5.5         Impact Analysis

6.           Latent TB Detection Market – Europe Analysis

6.1         Europe Latent TB Detection Market Revenue Forecast and Analysis

7.           Europe Latent TB Detection Market Analysis – By Test

7.1         Overview

7.2         Europe Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

7.4         Tuberculin Skin Test (TST)

7.4.1        Overview

7.4.2        Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

7.5         Interferon Gamma Released Assay (IGRA)

7.5.1        Overview

7.5.2        Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.           Europe Latent TB Detection Market Analysis – By End User

8.1         Overview

8.2         Europe Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

8.4         Hospitals

8.4.1        Overview

8.4.2        Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.5         Diagnostic Centers

8.5.1        Overview

8.5.2        Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.6         Laboratories

8.6.1        Overview

8.6.2        Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

9.           Europe Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis

9.1         Europe: Latent TB Detection Market

9.1.1        Overview

9.1.3        Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)

9.1.4        Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.6        France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7        Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Europe Latent TB Detection Market

10.1      Europe: Impact Assessment Of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      QIAGEN

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      bioMerieux SA

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      F. HOFFMANN-LA ROCHE LTD.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Abbott

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Oxford Immunotec Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Lionex GmbH

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      ARKRAY, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Serum Institute of India Pvt. Ltd.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)

Table 2.             Germany: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.             UK: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             France: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 7.             France: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 8.             Italy: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 9.             Italy: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Spain: Latent TB Detection Market, by Test – Revenue and Forecast to 2027 (USD Million)

Table 11.          Spain: Latent TB Detection Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12.          Organic Developments Done By Companies

Table 13.          Inorganic Developments Done By Companies

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Latent TB Detection Market Segmentation

Figure 2.           Europe Latent TB Detection Market – By Country

Figure 3.           Europe Latent TB Detection Market Overview

Figure 4.           Interferon Gamma Released Assay (IGRA) Segment Held Largest Share of Europe Latent TB Detection Market

Figure 5.           Germany to Show Remarkable Growth During Forecast Period

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Latent TB Detection Market Impact Analysis of Drivers and Restraint

Figure 9.           Europe Latent TB Detection Market – Revenue Forecast and Analysis

Figure 10.        Europe Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

Figure 11.        Europe Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Europe Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Europe Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

Figure 14.        Europe Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Europe Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Europe Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Europe Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Europe: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)

Figure 19.        Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)

Figure 20.        Germany: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        UK: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        France: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Italy: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Spain: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Impact of COVID-19 Pandemic in European Country Markets

The List of Companies - Europe Latent TB Detection Market

  1. Abbott
  2. ARKRAY, Inc.
  3. BD
  4. bioMerieux SA
  5. F. HOFFMANN-LA ROCHE LTD.
  6. Lionex GmbH
  7. Oxford Immunotec Ltd
  8. QIAGEN 
  9. Serum Institute of India Pvt. Ltd.